SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-025936
Filing Date
2015-04-29
Accepted
2015-04-29 16:11:08
Documents
9
Period of Report
2015-06-11
Effectiveness Date
2015-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A v408186_def14a.htm DEF 14A 386243
2 GRAPHIC v408186-pc1.jpg GRAPHIC 156114
3 GRAPHIC v408186-pc2.jpg GRAPHIC 254493
4 GRAPHIC v408186-pc3.jpg GRAPHIC 298867
5 GRAPHIC line.gif GRAPHIC 43
6 GRAPHIC logo_celator.jpg GRAPHIC 52326
7 GRAPHIC sig_mike-dougherty.jpg GRAPHIC 26049
8 GRAPHIC sig_scott-jackson.jpg GRAPHIC 11239
9 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-15-025936.txt   1489513
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36179 | Film No.: 15812846
SIC: 2834 Pharmaceutical Preparations